159 related articles for article (PubMed ID: 25342374)
21. Pulmonary manifestations of polymyositis/dermatomyositis.
Hallowell RW; Ascherman DP; Danoff SK
Semin Respir Crit Care Med; 2014 Apr; 35(2):239-48. PubMed ID: 24668538
[TBL] [Abstract][Full Text] [Related]
22. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease.
Gono T; Kawaguchi Y; Sugiura T; Ichida H; Takagi K; Katsumata Y; Hanaoka M; Okamoto Y; Ota Y; Yamanaka H
Rheumatology (Oxford); 2010 Oct; 49(10):1878-81. PubMed ID: 20601655
[TBL] [Abstract][Full Text] [Related]
24. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
Sharma N; Putman MS; Vij R; Strek ME; Dua A
J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644
[TBL] [Abstract][Full Text] [Related]
25. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA
Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary complications of inflammatory myopathy.
Ascherman DP
Curr Rheumatol Rep; 2002 Oct; 4(5):409-14. PubMed ID: 12217246
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporine treatment for interstitial pneumonitis associated with dermatomyositis/polymyositis.
Maeda K; Komuta K; Kuritani T; Igarashi T
Intern Med; 1998 Jan; 37(1):103. PubMed ID: 9510414
[No Abstract] [Full Text] [Related]
28. [Effective treatment of interstitial pneumonia with tacrolimus in a patient with dermatomyositis who was intolerant to cyclosporin-A].
Nuri K; Kotani T; Takeuchi T; Shoda T; Makino S; Hanafusa T
Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):444-8. PubMed ID: 20608089
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of steroid-resistant polymyositis and dermatomyositis].
Mimura T; Kanda H; Kubo K
Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
[TBL] [Abstract][Full Text] [Related]
30. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S
Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
[TBL] [Abstract][Full Text] [Related]
31. [Pulmonary involvement in polymyositis and dermatomyositis].
Tillie-Leblond I; Colin G; Lelong J; Cadranel J
Rev Mal Respir; 2006 Dec; 23(6):671-80. PubMed ID: 17202971
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of interstitial pneumonia associated with polymyositis/dermatomyositis with cyclosporin A].
Harigai M; Takagi K; Hara M
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):410-3. PubMed ID: 10726476
[No Abstract] [Full Text] [Related]
33. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M
Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306
[TBL] [Abstract][Full Text] [Related]
34. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
[TBL] [Abstract][Full Text] [Related]
35. Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease.
Kato Y; Yamamoto T
Int J Rheum Dis; 2017 May; 20(5):660-661. PubMed ID: 28397348
[No Abstract] [Full Text] [Related]
36. Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Polosa R; Edwards CJ
Eur Respir J; 2008 Jul; 32(1):244-5; author reply 245-6. PubMed ID: 18591348
[No Abstract] [Full Text] [Related]
37. Pulmonary manifestations of the idiopathic inflammatory myopathies.
Kalluri M; Oddis CV
Clin Chest Med; 2010 Sep; 31(3):501-12. PubMed ID: 20692542
[TBL] [Abstract][Full Text] [Related]
38. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI
J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
[TBL] [Abstract][Full Text] [Related]
39. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
Chen YJ; Wu CY; Shen JL
Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
[TBL] [Abstract][Full Text] [Related]
40. Polymyositis-dermatomyositis-associated interstitial lung disease.
Douglas WW; Tazelaar HD; Hartman TE; Hartman RP; Decker PA; Schroeder DR; Ryu JH
Am J Respir Crit Care Med; 2001 Oct; 164(7):1182-5. PubMed ID: 11673206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
